NLRP2 negatively regulates antiviral immunity by interacting with TBK1

Eur J Immunol. 2018 Nov;48(11):1817-1825. doi: 10.1002/eji.201847589. Epub 2018 Sep 6.

Abstract

Nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs) are intracellular pattern recognition receptors (PRRs) that regulate a variety of inflammatory and host defense responses. Unlike the well-established NLRs, the roles of NLRP2 are controversial and poorly defined. Here, we report that NLRP2 acts as a negative regulator of TANK-binding kinase 1 (TBK1)-mediated type I interferon (IFN) signaling. Mechanistically, NLRP2 interacted directly with TBK1, and this binding disrupted the interaction of TBK1 and interferon regulatory factor 3 (IRF3), which interfered with TBK1-induced IRF3 phosphorylation. IFNs induce a series of proteins that have well-known antiviral or immune-regulatory functions, and tight control of the IFN signaling cascade is critical for limiting tissue damage and preventing autoimmunity. Our studies indicate that the NLRP2-TBK1 axis may serve as an additional signaling cascade to maintain immune homeostasis in response to viral infection.

Keywords: Antiviral innate immunity; NLRP2; TBK1; Type I interferons.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • A549 Cells
  • Adaptor Proteins, Signal Transducing / metabolism*
  • Apoptosis Regulatory Proteins
  • Cell Line
  • Cell Line, Tumor
  • HEK293 Cells
  • Humans
  • Interferon Regulatory Factor-3 / metabolism
  • Interferon Type I / metabolism
  • Phosphorylation / physiology
  • Protein Binding / physiology
  • Protein Serine-Threonine Kinases / metabolism*
  • Signal Transduction / physiology

Substances

  • Adaptor Proteins, Signal Transducing
  • Apoptosis Regulatory Proteins
  • Interferon Regulatory Factor-3
  • Interferon Type I
  • NLRP2 protein, human
  • Protein Serine-Threonine Kinases
  • TBK1 protein, human